Prepared: July 22, 2026 | Upcoming Earnings: Q2 2026 (expected late July 2026) | Last Earnings: Q1 2026, reported April 28, 2026
Key Takeaway: Setup is mixed — the Americas non-residential core remains healthy and the bar is achievable, but the single biggest swing factor is whether the International segment's ERP recovery is tracking as promised heading into Q2.
Heading into Q2 2026, Allegion's setup is one of a company with a solid core but a self-inflicted overhang. Americas non-residential organic growth — the engine of the business — is expected to continue at mid-single digits, supported by strong spec activity, resilient institutional demand, and price realization, with management explicitly guiding for volume growth in non-res for the full year. The International ERP recovery is the critical variable: management guided at Q1 earnings that the Q1 shortfall would be recovered over Q2–Q4, and at the June 9 Wells Fargo conference CEO Stone confirmed the business has "largely stopped the revenue bleed" and is back to producing and selling at rate — but Q2 margins in International are still expected to be "a little softer versus last year," meaning the recovery is back-half weighted. Consensus adjusted EPS for Q2 2026 stands at ~$2.21, implying meaningful year-over-year growth from $2.04 in Q2 2025, a bar that requires Americas margin stability and at least sequential International improvement. The stock has underperformed XLI (+4.6%) and SPY (+5.0%) materially since the Q1 print, down only ~1.5% in absolute terms but lagging the market by ~350–500 bps, suggesting the market has not yet rewarded the recovery narrative. The wildcard is tariff pricing realization: Allegion announced pricing actions post-Q1 that are not yet in the market, and the degree to which those surcharges or list price increases land in Q2 revenue and protect margins will determine whether the company can hold its full-year EPS guide of $8.70–$8.90.
Key Takeaway: Consensus sets a moderately achievable bar on revenue (~$1.12B, +15.7% reported YoY) but a more demanding one on adjusted EPS (~$2.21 vs. $2.04 in Q2 2025). The bigger swing factor is International organic growth — consensus expects roughly flat to slightly negative organically, but any upside from the ERP recovery could surprise positively on both revenue and margin.
KPI | Last Quarter Actual (Q1 2026) | Prior Year Period (Q2 2025) | Q2 2026 Consensus Estimate | YoY Change (vs. Q2 2025) | FY 2026 Guidance | Consensus vs. Guidance Midpoint |
Total Revenue ($M) | $1,033.6M | $1,022.0M | $1,117.4M | +9.3% | +6% to +8% reported | N/A (FY metric) |
Americas Revenue ($M) | $809.9M | $821.5M | $881.3M | +7.3% | N/A (segment) | N/A |
International Revenue ($M) | $223.7M | $200.5M | $236.1M | +17.7% | N/A (segment) | N/A |
Organic Revenue Growth — Total (%) | +2.6% | +3.2% | +3.7% | +50 bps vs. Q2 2025 | +2% to +4% | ~+70 bps above midpoint |
Organic Revenue Growth — Americas (%) | +4.5% | +4.5% | +4.8% | +30 bps vs. Q2 2025 | N/A (segment) | N/A |
Organic Revenue Growth — International (%) | -5.3% | -2.2% | -0.9% | Improvement from -5.3% in Q1 | N/A (segment) | N/A |
Adj. EPS — Diluted Operating ($) | $1.80 | $2.04 | $2.21 | +8.3% | $8.70–$8.90 | ~+2.5% above midpoint |
EBITA Margin — Operating (%) | 21.2% | 23.7% | 23.4% | -30 bps vs. Q2 2025 | N/A (FY metric) | N/A |
Americas EBITA Margin — Operating (%) | 28.1% | 29.9% | 29.7% | -20 bps vs. Q2 2025 | N/A (segment) | N/A |
International EBITA Margin — Operating (%) | 8.0% | 13.1% | 11.2% | -190 bps vs. Q2 2025 | N/A (segment) | N/A |
Free Cash Flow ($M) | $80.3M | $192.0M | $195.0M | +1.6% | 85–95% of adj. net income | N/A |
Source: Visible Alpha Consensus and Actuals Data. Q1 2026 actuals from ALLE Q1 2026 Earnings Release (April 28, 2026). FY 2026 guidance from Q1 2026 earnings call. All consensus figures as of July 22, 2026.
Quarter | Reported ($M) | Consensus ($M) | Surprise % | Result |
Q2 2024 | $965.6M | $957.9M | +0.8% | Beat |
Q3 2024 | $967.1M | $968.9M | -0.2% | Miss |
Q4 2024 | $945.6M | $937.9M | +0.8% | Beat |
Q1 2025 | $941.9M | $923.1M | +2.0% | Beat |
Q2 2025 | $1,022.0M | $1,007.0M | +1.5% | Beat |
Q3 2025 | $1,070.2M | $1,044.0M | +2.5% | Beat |
Q4 2025 | $1,033.2M | $1,035.9M | -0.3% | Miss |
Q1 2026 | $1,033.6M | $1,025.2M | +0.8% | Beat |
Pattern: ALLE has beaten revenue consensus in 6 of the last 8 quarters, with misses concentrated in Q3 2024 and Q4 2025 (both within -0.3%). Revenue beats have been consistent and modest, suggesting consensus tends to be set slightly below achievable levels.
Quarter | Reported ($) | Consensus ($) | Surprise % | Result |
Q2 2024 | $1.96 | $1.83 | +7.1% | Beat |
Q3 2024 | $2.16 | $1.98 | +9.1% | Beat |
Q4 2024 | $1.86 | $1.76 | +5.7% | Beat |
Q1 2025 | $1.86 | $1.67 | +11.4% | Beat |
Q2 2025 | $2.04 | $1.99 | +2.5% | Beat |
Q3 2025 | $2.30 | $2.20 | +4.5% | Beat |
Q4 2025 | $1.94 | $1.98 | -2.0% | Miss |
Q1 2026 | $1.80 | $1.88 | -4.3% | Miss |
Pattern: ALLE beat adjusted EPS consensus in 6 of the last 8 quarters, often by wide margins (7–11%), but the last two quarters (Q4 2025 and Q1 2026) were misses driven by acquisition dilution, higher taxes/interest, and the International ERP disruption. The Q2 2026 bar of $2.21 requires a meaningful step-up from Q1’s $1.80, consistent with management’s guidance for a back-half-weighted year.
Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: Guidance has been stable since Q1 earnings with one upward revision to reported revenue (to include the DCI acquisition). Management tone has shifted from cautious to incrementally more confident on the International recovery, while acknowledging tariff-driven margin rate pressure that is expected to be offset at the operating income and EPS level.
Metric | Initial Guidance (Q1 2026 Earnings Call, Apr 28) | Revised Guidance | Current Consensus | Note |
Reported Revenue Growth | +6% to +8% (raised 1 pt at Q1 to include DCI acquisition) | — | ~+7.5% implied by $4.40B FY consensus | Raised at Q1 earnings to include DCI; affirmed at Wells Fargo June 9 conference |
Organic Revenue Growth | +2% to +4% | — | ~+4.0% (FY 2026 consensus) | Affirmed at Q1 earnings and at Wells Fargo June 9; pricing actions not yet in market as of Q1 |
Adjusted EPS | $8.70–$8.90 | — | $8.77 | Affirmed at Q1 earnings; management expects tariff headwind (~1% of COGS) to be offset at EPS level via price + cost actions |
Americas Organic Growth | Volume growth expected in non-res for FY; resi flat to slightly negative | — | ~+4.9% Americas organic (FY 2026 consensus) | Tone: confident; spec activity described as "very strong and broad-based" at June 9 conference |
International Organic Growth | Q1 shortfall to be recovered over Q2–Q4; sequential improvement each quarter | — | ~-0.9% Q2 2026 consensus; ~+0.3% FY 2026 consensus | ↑ Tone improved: CEO confirmed at June 9 Wells Fargo conf. business has "largely stopped the revenue bleed" and is back to producing and selling at rate |
Americas Adj. Operating Margin | Q2: no big headwinds YoY but not much expansion; expansion weighted to Q3/Q4 | — | ~29.7% Q2 2026 consensus | Margin rate pressure from tariff/inflation acknowledged; dollar-basis offset expected |
International Adj. Operating Margin | Q2: "a little softer versus last year on margin rates"; sequential improvement from Q1 2026 | — | ~11.2% Q2 2026 consensus (vs. 13.1% in Q2 2025) | ERP recovery ongoing; DCI acquisition adds ~30 bps margin rate headwind for full year |
Free Cash Flow Conversion | 85–95% of adjusted net income | — | ~$725M FY 2026 consensus | Affirmed; Q1 FCF of $80M was seasonally low (typical pattern) |
Source: ALLE Q1 2026 Earnings Call transcript (April 28, 2026); ALLE Wells Fargo Industrials & Materials Conference transcript (June 9, 2026); Visible Alpha Consensus Data.
Key Takeaway: Estimates have been broadly stable since the Q1 print, with Q2 2026 revenue consensus up ~$6M and EPS up ~$0.01 since the post-earnings baseline — essentially flat. FY 2026 estimates have drifted modestly higher on revenue (+$23M) and EPS (+$0.04), suggesting the market has largely accepted management’s guidance and is not pricing in meaningful upside or downside from the International recovery.
KPI (Period) | Estimate ~5 Days Post Q1 Earnings (May 5, 2026) | Current Consensus (Jul 22, 2026) | Estimate Δ (%) | Initial Guidance (Q1 Earnings Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance Midpoint |
Total Revenue — Q2 2026 | $1,111.4M | $1,117.4M | +0.5% | N/A (no quarterly guidance) | N/A | N/A | N/A |
Total Revenue — FY 2026 | $4,375M | $4,398M | +0.5% | +6% to +8% reported growth | +6% to +8% (unchanged) | No change | ~+7.5% implied; within range |
Organic Growth — Q2 2026 (%) | +3.5% | +3.7% | +20 bps | N/A (no quarterly guidance) | N/A | N/A | N/A |
Organic Growth — FY 2026 (%) | +3.6% | +4.0% | +40 bps | +2% to +4% | +2% to +4% (unchanged) | No change | ~+100 bps above midpoint; at top of range |
Adj. EPS — Q2 2026 ($) | $2.20 | $2.21 | +0.5% | N/A (no quarterly guidance) | N/A | N/A | N/A |
Adj. EPS — FY 2026 ($) | $8.73 | $8.77 | +0.5% | $8.70–$8.90 | $8.70–$8.90 (unchanged) | No change | ~-3 cents below midpoint ($8.80); within range |
EBITA Margin — Q2 2026 (%) | 23.4% | 23.4% | Flat | N/A (no quarterly guidance) | N/A | N/A | N/A |
Estimates have barely moved since the Q1 print — all revisions are within +0.5% — indicating the sell-side has accepted management’s guidance framework and is not building in incremental upside from the International recovery or pricing actions. FY 2026 organic growth consensus of ~+4.0% sits at the top of the +2%–+4% guidance range, implying the market expects a clean execution of the recovery. Any positive surprise on International margins or pricing realization in Q2 could be a catalyst for upward EPS revisions.
Source: Visible Alpha Consensus and Actuals Data. Post-earnings baseline as of May 5, 2026 (5 trading days after April 28, 2026 earnings).
Key Takeaway: ALLE has significantly underperformed both XLI (+4.6%) and SPY (+5.0%) since the Q1 2026 earnings print, gaining only ~+1.5% in absolute terms. The underperformance is driven by multiple compression and sentiment reset following the EPS miss and International ERP disruption, not by estimate revisions (which have been flat). The stock has partially recovered from its May lows (~$125) but remains well below pre-earnings levels (~$148), suggesting the market is waiting for proof of the International recovery before re-rating.
ALLE vs XLI (Industrials ETF) vs S&P 500 (SPY) — Indexed to 100 at Q1 2026 Earnings (April 28, 2026). XLI selected as the sector ETF given ALLE’s classification in the Industrials sector (security products & building hardware). Source: Stock Price Data.
Since the Q1 2026 earnings print on April 28, ALLE fell sharply from ~$148 to a trough of ~$125 by mid-May (a ~16% peak-to-trough decline), driven by the EPS miss and International ERP disruption. The stock has since recovered to ~$140, but remains ~6% below pre-earnings levels. XLI and SPY both rallied meaningfully over the same period (+4.6% and +5.0% respectively), widening the relative underperformance gap to ~500–650 bps. The Wells Fargo conference on June 9 (marked on chart) provided a modest catalyst as CEO Stone confirmed the International business had stabilized, contributing to the late-June recovery. The stock’s inability to fully recover to pre-earnings levels despite stable estimates suggests the market is applying a valuation discount pending Q2 proof points on the International recovery and tariff pricing realization.
Source: Stock Price Data (Yahoo Finance).
Key Takeaway: Peer commentary from the last 60 days is broadly constructive for ALLE’s Q2 setup. Non-residential commercial demand remains resilient across building products peers, pricing actions are being implemented and accepted, and the security/access control end market is showing strength. The most relevant read-throughs come from Resideo (ADI distribution channel), Carrier (commercial HVAC demand signals), and Johnson Controls (non-res institutional demand). OTIS’s Q2 2026 results (reported July 22) confirm strong non-res demand in Americas.
Note: Only commentary from the current reporting period (Q2 2026) or post-Q1 2025 earnings is included. Prior-quarter earnings commentary about prior-quarter results is excluded.
Relevance to ALLE: ADI Global Distribution is one of the largest distributors of security, access control, and low-voltage building products in North America — a key channel partner for ALLE’s electronic locks and access control products. ADI’s commentary on commercial security demand, pricing, and channel inventory is a direct read-through for ALLE’s Americas electronics business.
Relevance to ALLE: Carrier is a leading commercial HVAC and building products company with significant exposure to non-residential construction — the same end market that drives ~80% of ALLE’s Americas revenue. Carrier’s commentary on commercial demand, pricing realization, and tariff management is a direct read-through for ALLE’s Americas non-residential business.
Relevance to ALLE: Johnson Controls is a major building technology and HVAC company with deep exposure to institutional non-residential construction (data centers, healthcare, advanced manufacturing). JCI’s commentary on institutional demand and order trends is a read-through for the broader non-residential construction cycle that underpins ALLE’s spec-driven demand model.
Relevance to ALLE: Otis is a global elevator and escalator company with significant Americas non-residential construction exposure. As a same-day reporter, Otis’s Q2 2026 results provide the most timely read-through on current non-residential demand conditions heading into ALLE’s print.
Relevance to ALLE: SWK is a building products and tools company with exposure to both professional construction and residential end markets. Its commentary on tariff management, pricing, and the construction demand environment provides a read-through for ALLE’s Americas business.
Peer | Source / Date | Key Signal for ALLE | Direction |
REZI (ADI) | Q1 Earnings (May 12); Baird Conf. (Jun 2); Investor Day (Jul 13) | Commercial security returning to growth; pricing accepted; Q2 lapping headwind; H2 inflection expected | Mixed / Positive |
CARR | Wells Fargo Conf. (Jun 9) | Non-res demand strong across verticals; Q2 on track; pricing realization progressing; resi better than feared | Positive |
JCI | Gemba Day (Jun 1) | Record orders/backlog; institutional non-res demand robust; data center growth validates ALLE’s positioning | Positive |
OTIS | Q2 2026 Earnings (Jul 22) | Americas non-res orders +15%; 8 straight quarters of growth; modernization backlog +26%; margin pressure from labor/materials | Positive / Cautious on margins |
SWK | Wells Fargo Conf. (Jun 9) | 301 tariffs returning Jul 25 (risk); professional markets outperforming DIY; H2 margin recovery narrative consistent with ALLE | Mixed |
Key Takeaway: The most important development since Q1 earnings is management’s June 9 confirmation that the International ERP business has "largely stopped the revenue bleed" — this is the critical proof point the market needs to re-rate the stock. The secondary development is the announcement of pricing actions to offset tariff headwinds, which are not yet in market revenue but are expected to protect EPS.
Key Takeaway: No open-market buys or discretionary sells by executives since the Q1 earnings print. The only notable transaction is a small open-market sale by SVP & Chief Innovation Officer Robert Martens (May 7, ~$3,993 shares) — not on a 10b5-1 plan, but the size is modest. Director transactions in June are routine equity award-related (Form 4 code ‘A’ = award, ‘F’ = tax withholding). No clustered insider buying to signal conviction, but also no large discretionary selling — neutral signal overall.
Name | Title | Transaction Type | Shares | Transaction Date | Note |
Martens, Robert C. | SVP — Chief Innovation & Design | Open Market Sale | 3,993 shares | May 7, 2026 | Discretionary sale; not on 10b5-1 plan; modest size relative to 8,570 shares owned post-transaction |
Multiple Directors (6) | Board of Directors | Equity Award (Grant) | 1,074–1,649 shares each | June 4, 2026 | Routine annual equity award (Form 4 code ‘A’); not open-market purchases; directors: Main, Mizell, Parent Haughey, Peters, Rubin, Sengstack, Vardhan |
Multiple Directors (6) | Board of Directors | Tax Withholding (Share Surrender) | 292–449 shares each | June 5, 2026 | Routine tax withholding on equity award vesting (Form 4 code ‘F’); obligation-driven, not discretionary selling |
Blasko, Joseph | SVP and General Counsel | Tax Withholding (Share Surrender) | 145 shares | July 2, 2026 | Routine tax withholding on equity vesting (Form 4 code ‘F’); obligation-driven, not discretionary |
The only transaction of note is the May 7 open-market sale by SVP Martens (3,993 shares), which occurred shortly after the Q1 earnings miss and stock decline. While not on a 10b5-1 plan, the size is modest and does not constitute a meaningful bearish signal. The absence of any open-market buying by executives at post-earnings depressed prices (~$125–$135) is notable — management has instead signaled confidence through the board-authorized share repurchase program rather than personal purchases.
Source: Insider Transaction Data (SEC Form 4 filings).